Ausdal Financial Partners, Inc. Q4 2020 Filing

Filed February 1, 2021

Portfolio Value

$513.6B

Holdings

417

Report Date

Q4 2020

Filing Type

13F-HR

All Holdings (417 positions)

#StockSharesValue% PortfolioType
401
AROCARCHROCK INC
15,000$130.0M0.03%
402
TEVATEVA PHARMACEUTICAL INDS LTD
25,348$130.0M0.03%
403
PFNPIMCO INCOME STRATEGY FD II
12,869$128.0M0.02%
404
GWG HLDGS INC
15,686$110.0M0.02%
405
VOYA PRIME RATE TR
20,000$89.0M0.02%
406
SABRSABRE CORP
11,000$88.0M0.02%
407
OPKOPKO HEALTH INC
24,000$83.0M0.02%
408
BKCCUSDBLACKROCK CAP INVT CORP
30,511$82.0M0.02%
409
WSRWHITESTONE REIT
10,000$80.0M0.02%
410
OFSOFS CAP CORP
11,045$79.0M0.02%
411
AMRNAMARIN CORP PLC
15,398$69.0M0.01%
412
NEANUVEEN SR INCOME FD
12,274$64.0M0.01%
413
TIZIANA LIFE SCIENCES PLC
26,200$53.0M0.01%
414
VIRNETX HLDG CORP
10,190$51.0M0.01%
415
TREVENA INC
10,000$21.0M0.00%
416
ACELRX PHARMACEUTICALS INC
16,000$20.0M0.00%
417
SENS1GBPSENSEONICS HLDGS INC
15,000$13.0M0.00%
PreviousPage 5 of 5